Literature DB >> 24178374

Disseminated infection due to Saksenaea vasiformis secondary to cutaneous mucormycosis.

Cristina Gómez-Camarasa1, María Dolores Rojo-Martín, Consuelo Miranda-Casas, Ana Alastruey-Izquierdo, Luis Aliaga-Martínez, José Miguel Labrador-Molina, José María Navarro-Marí.   

Abstract

Mucormycosis is an uncommon opportunistic fungal infection caused by Zygomycetes. It usually affects immunocompromised, diabetic and trauma patients with infected wounds. We report a case of disseminated infection secondary to facial cutaneous mucormycosis caused by Saksenaea vasiformis in a diabetic patient who had a farming accident causing him severe head injury. The patient was treated with a combination of surgical debridement and antifungal therapy with liposomal amphotericin B, but he had a slow and fatal outcome. In cases of tissue necrosis following trauma involving wound contact with soil (i.e., potential fungal contamination), testing for the presence of Zygomycetes fungi such as S. vasiformis in both immunocompetent and immunocompromised patients is crucial. The reason is that this infection usually has a rapid progression and may be fatal if appropriate treatment is not administered.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24178374     DOI: 10.1007/s11046-013-9715-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  22 in total

1.  [Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update].

Authors:  Josefina Ayats; Estrella Martín-Mazuelos; Javier Pemán; Guillermo Quindós; Fernando Sánchez; Julio García-Rodríguez; Josep Guarro; Jesús Guinea; María J Linares; José Pontón; Juan L Rodríguez-Tudela; Manuel Cuenca-Estrella
Journal:  Enferm Infecc Microbiol Clin       Date:  2010-12-22       Impact factor: 1.731

2.  Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).

Authors:  Thomas J Walsh; Maria N Gamaletsou; Michael R McGinnis; Randall T Hayden; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 3.  Healthcare-associated mucormycosis.

Authors:  Blandine Rammaert; Fanny Lanternier; Jean-Ralph Zahar; Eric Dannaoui; Marie-Elisabeth Bougnoux; Marc Lecuit; Olivier Lortholary
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

4.  Saksenaea vasiformis infections: case report and literature review.

Authors:  William Vega; Margot Orellana; Luis Zaror; Josepa Gené; Josep Guarro
Journal:  Mycopathologia       Date:  2006-10       Impact factor: 2.574

Review 5.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis.

Authors:  S J Taj-Aldeen; A Falamarzi; A AlMuzrkchi; J Guarro
Journal:  Infection       Date:  2012-09-24       Impact factor: 3.553

7.  Rhinocerebral zygomycosis caused by Saksenae vasiformis in a diabetic patient.

Authors:  Jesús García-Martínez; Francisco López-Medrano; Almudena Alhambra; Amalia del Palacio
Journal:  Mycoses       Date:  2008-04-16       Impact factor: 4.377

Review 8.  Liposomal amphotericin B: what is its role in 2008?

Authors:  F Lanternier; O Lortholary
Journal:  Clin Microbiol Infect       Date:  2008-05       Impact factor: 8.067

9.  Fatal rhino-orbito-cerebral infection caused by Saksenaea vasiformis in an immunocompetent individual: first case report from India.

Authors:  V P Baradkar; M Mathur; S Taklikar; M Rathi; S Kumar
Journal:  Indian J Med Microbiol       Date:  2008 Oct-Dec       Impact factor: 0.985

10.  Cutaneous zygomycosis due to Saksenaea vasiformis in an immunocompetent host.

Authors:  V P Baradkar; S Kumar
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more
  4 in total

1.  Rhizopus arrhizus Invasive Infection due to Self-Inflicted Scratch Injuries in a Diabetic Patient with Non-ketotic Acidosis.

Authors:  Luis Buzón Martín; Miguel Ángel Morán Rodríguez; Nicole Mercier; Maria Ortega Lafont; Eva Ojeda Fernández; Ana Ruiz de la Parte; Miguel Estefanía
Journal:  Mycopathologia       Date:  2017-06-23       Impact factor: 2.574

2.  Acute ischemia of bilateral lower extremities as a presenting feature of disseminated mucormycosis endocarditis: A case report.

Authors:  Niranjan Tachamo; Priya Rajagopalan; Salik Nazir; Saroj Lohani; Brian Le; Nitin Patel
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-12-15

3.  Cutaneous Invasive Fungal Infections with Saksenaea Species in Immunocompetent Patients in Europe: A Systematic Review and Case Report.

Authors:  Andrea Planegger; Semra Uyulmaz; Audrius Poskevicius; Andrea Zbinden; Nicolas J Müller; Maurizio Calcagni
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-04-08

Review 4.  The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance.

Authors:  Md Rezaul Islam; Md Mominur Rahman; Md Tanjimul Ahasan; Nadia Sarkar; Shopnil Akash; Mahfuzul Islam; Fahadul Islam; Most Nazmin Aktar; Mohd Saeed; Md Harun-Or-Rashid; Md Kawsar Hosain; Md Saidur Rahaman; Sadia Afroz; Shabana Bibi; Md Habibur Rahman; Sherouk Hussein Sweilam
Journal:  Environ Sci Pollut Res Int       Date:  2022-08-19       Impact factor: 5.190

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.